Literature DB >> 18280143

The effect of pharmaceuticals on the kinetics of methanogenesis and acetogenesis.

M S Fountoulakis1, K Stamatelatou, G Lyberatos.   

Abstract

In this study, the widely used anaerobic digestion model (ADM1) was used in order to simulate the inhibition of three pharmaceuticals, propranolol hydrochloride, ofloxacin and diclofenac sodium, on two groups of microorganisms, acetogens and acetoclastic methanogens, the most sensitive microorganisms groups involved in the anaerobic digestion process. The specific maximum consumption rate and saturation constant of acetate and propionate degraders were estimated through fitting the model to experimental data taken from continuous and batch experiments. A modified non-competitive inhibition function was used, and the inhibition constants were estimated using data from Batch experiments conducted at various concentrations of pharmaceuticals using enriched cultures with propionate and acetate degraders. It was found that propranolol hydrochloride was the most inhibitory pharmaceutical to both microorganisms groups.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18280143     DOI: 10.1016/j.biortech.2008.01.008

Source DB:  PubMed          Journal:  Bioresour Technol        ISSN: 0960-8524            Impact factor:   9.642


  3 in total

1.  Acute effect of benzo[a]anthracene on the biodegradation of peptone under aerobic conditions.

Authors:  Serden Başak; Emine Ubay Cokgör; Güçlü Insel; Derin Orhon
Journal:  Environ Sci Pollut Res Int       Date:  2012-04-15       Impact factor: 4.223

2.  Aerobic inhibition assessment for anaerobic treatment effluent of antibiotic production wastewater.

Authors:  Zeynep Cetecioglu
Journal:  Environ Sci Pollut Res Int       Date:  2013-10-22       Impact factor: 4.223

Review 3.  Microbial transformation of widely used pharmaceutical and personal care product compounds.

Authors:  Abigail W Porter; Sarah J Wolfson; Max Häggblom; Lily Y Young
Journal:  F1000Res       Date:  2020-02-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.